Lee Duna@lemmy.nz to Science@beehaw.orgEnglish · 2 years agoFirst trial of ‘base editing’ in humans lowers cholesterol — but raises safety concernswww.nature.comexternal-linkmessage-square2linkfedilinkarrow-up137arrow-down10cross-posted to: futurology@futurology.today
arrow-up137arrow-down1external-linkFirst trial of ‘base editing’ in humans lowers cholesterol — but raises safety concernswww.nature.comLee Duna@lemmy.nz to Science@beehaw.orgEnglish · 2 years agomessage-square2linkfedilinkcross-posted to: futurology@futurology.today
minus-squareappel@whiskers.bim.boatslinkfedilinkarrow-up1·2 years agoCool picture. From what I gather they did not use a viral vector here? It mentions nanoparticles. I also wonder if there were any adverse affects among the animal tests too.
Cool picture. From what I gather they did not use a viral vector here? It mentions nanoparticles. I also wonder if there were any adverse affects among the animal tests too.
Yeah looks like lipid nanoparticles.